These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate. Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650 [TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506 [TBL] [Abstract][Full Text] [Related]
7. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate. Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354 [TBL] [Abstract][Full Text] [Related]
8. Recent advances and patents on solid lipid nanoparticles. Sawant KK; Dodiya SS Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903 [TBL] [Abstract][Full Text] [Related]
13. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233 [TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles as drug delivery systems. Manjunath K; Reddy JS; Venkateswarlu V Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465 [TBL] [Abstract][Full Text] [Related]
15. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status. Liu M; Wen J; Sharma M Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322 [TBL] [Abstract][Full Text] [Related]
16. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Haider M; Abdin SM; Kamal L; Orive G Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127 [TBL] [Abstract][Full Text] [Related]
17. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Danaei M; Dehghankhold M; Ataei S; Hasanzadeh Davarani F; Javanmard R; Dokhani A; Khorasani S; Mozafari MR Pharmaceutics; 2018 May; 10(2):. PubMed ID: 29783687 [TBL] [Abstract][Full Text] [Related]
18. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review. Gunawan M; Boonkanokwong V Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866 [TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanocarriers in drug delivery: characterization and design. Mu H; Holm R Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267 [TBL] [Abstract][Full Text] [Related]
20. Development and tailoring of hybrid lipid nanocarriers. Islan GA; Cacicedo ML; Rodenak-Kladniew B; Duran N; Castro GR Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29141536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]